# Tofacitinib Registry of Patients With Ulcerative Colitis in Germany

> **NCT04032756** · — · TERMINATED · sponsor: **Ced Service GmbH** · enrollment: 50 (actual)

## Conditions studied

- Colitis, Ulcerative
- Biologics
- Tofacitiniib
- Chronic Inflammatory Small Bowel Disease
- Bowel Diseases, Inflammatory
- Bowel Disease
- CED

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04032756
- **Lead sponsor:** Ced Service GmbH
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-01
- **Primary completion:** 2020-11-15
- **Final completion:** 2020-11-15
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** not enough patients recruited, Study objective could not be achieved
- **Last updated:** 2021-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04032756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04032756, "Tofacitinib Registry of Patients With Ulcerative Colitis in Germany". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04032756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*